These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 9295329

  • 21. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
    Orgel D, Schröder W, Hecker-Kia A, Weithmann KU, Kolkenbrock H, Ulbrich N.
    Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
    [Abstract] [Full Text] [Related]

  • 22. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T, Goswami S, McClintock CS, Ramsey MT, Peterson CB.
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [Abstract] [Full Text] [Related]

  • 23. Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation.
    Kromann-Hansen T, Lange EL, Lund IK, Høyer-Hansen G, Andreasen PA, Komives EA.
    PLoS One; 2018 Feb; 13(2):e0192661. PubMed ID: 29420634
    [Abstract] [Full Text] [Related]

  • 24. Structure of human urokinase plasminogen activator in complex with its receptor.
    Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J, Li Y, Yuan C, Bian C, Chen L, Furie B, Furie BC, Cines DB, Huang M.
    Science; 2006 Feb 03; 311(5761):656-9. PubMed ID: 16456079
    [Abstract] [Full Text] [Related]

  • 25. Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.
    Yasuda S, Morokawa N, Wong GW, Rossi A, Madhusudhan MS, Sali A, Askew YS, Adachi R, Silverman GA, Krilis SA, Stevens RL.
    Blood; 2005 May 15; 105(10):3893-901. PubMed ID: 15701722
    [Abstract] [Full Text] [Related]

  • 26. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
    Husain SS.
    Biochemistry; 1991 Jun 11; 30(23):5797-805. PubMed ID: 1828371
    [Abstract] [Full Text] [Related]

  • 27. Binding of nonphysiological protein and peptide substrates to proteases: differences between urokinase-type plasminogen activator and trypsin and contributions to the evolution of regulated proteolysis.
    Bergstrom RC, Coombs GS, Ye S, Madison EL, Goldsmith EJ, Corey DR.
    Biochemistry; 2003 May 13; 42(18):5395-402. PubMed ID: 12731881
    [Abstract] [Full Text] [Related]

  • 28. The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase.
    Lenich C, Pannell R, Henkin J, Gurewich V.
    Thromb Haemost; 1992 Nov 10; 68(5):539-44. PubMed ID: 1455401
    [Abstract] [Full Text] [Related]

  • 29. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1.
    Sipley JD, Alexander DS, Testa JE, Quigley JP.
    Proc Natl Acad Sci U S A; 1997 Apr 01; 94(7):2933-8. PubMed ID: 9096324
    [Abstract] [Full Text] [Related]

  • 30. Pro-urokinase-type plasminogen activator is a substrate for hepsin.
    Moran P, Li W, Fan B, Vij R, Eigenbrot C, Kirchhofer D.
    J Biol Chem; 2006 Oct 13; 281(41):30439-46. PubMed ID: 16908524
    [Abstract] [Full Text] [Related]

  • 31. Prourokinase mutant that induces highly effective clot lysis without interfering with hemostasis.
    Liu JN, Liu JX, Liu Bf BF, Sun Z, Zuo JL, Zhang Px PX, Zhang J, Chen Yh YH, Gurewich V.
    Circ Res; 2002 Apr 19; 90(7):757-63. PubMed ID: 11964367
    [Abstract] [Full Text] [Related]

  • 32. Interconversion of active and inactive conformations of urokinase-type plasminogen activator.
    Liu Z, Kromann-Hansen T, Lund IK, Hosseini M, Jensen KJ, Høyer-Hansen G, Andreasen PA, Sørensen HP.
    Biochemistry; 2012 Oct 02; 51(39):7804-11. PubMed ID: 22950516
    [Abstract] [Full Text] [Related]

  • 33. Expression and characterization of recombinant human micro-plasminogen.
    Ma Z, Lu W, Wu S, Chen J, Sun Z, Liu JN.
    Biotechnol Lett; 2007 Apr 02; 29(4):517-23. PubMed ID: 17206368
    [Abstract] [Full Text] [Related]

  • 34. Autoactivation of avian urokinase-type plasminogen activator (uPA). A novel mode of initiation of the uPA/plasmin cascade.
    Alexander DS, Sipley JD, Quigley JP.
    J Biol Chem; 1998 Mar 27; 273(13):7457-61. PubMed ID: 9516444
    [Abstract] [Full Text] [Related]

  • 35. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility.
    Egelund R, Schousboe SL, Sottrup-Jensen L, Rodenburg KW, Andreasen PA.
    Eur J Biochem; 1997 Sep 15; 248(3):775-85. PubMed ID: 9342229
    [Abstract] [Full Text] [Related]

  • 36. Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.
    De Taeye B, Gils A, Vleugels N, Rabijns A, Declerck PJ.
    Biochem Biophys Res Commun; 2004 Aug 27; 321(3):746-51. PubMed ID: 15358169
    [Abstract] [Full Text] [Related]

  • 37. Distinctive binding modes and inhibitory mechanisms of two peptidic inhibitors of urokinase-type plasminogen activator with isomeric P1 residues.
    Jiang L, Zhao B, Xu P, Sørensen HP, Jensen JK, Christensen A, Hosseini M, Nielsen NC, Jensen KJ, Andreasen PA, Huang M.
    Int J Biochem Cell Biol; 2015 May 27; 62():88-92. PubMed ID: 25744057
    [Abstract] [Full Text] [Related]

  • 38. Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.
    Ji HL, Zhao R, Komissarov AA, Chang Y, Liu Y, Matthay MA.
    J Biol Chem; 2015 Feb 27; 290(9):5241-55. PubMed ID: 25555911
    [Abstract] [Full Text] [Related]

  • 39. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity.
    Greenwald J, Le V, Butler SL, Bushman FD, Choe S.
    Biochemistry; 1999 Jul 13; 38(28):8892-8. PubMed ID: 10413462
    [Abstract] [Full Text] [Related]

  • 40. Human/chicken urokinase chimeras demonstrate sequences outside the serine protease domain that dictate autoactivation.
    Aimes RT, Regazzoni K, Quigley JP.
    Thromb Haemost; 2003 Feb 13; 89(2):382-92. PubMed ID: 12574820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.